Role of NOD2 and RIP2 in host–microbe interactions with Gram-negative bacteria: insights from the periodontal disease model

NOD2 is a member of the NLR family of proteins that participate in the activation of the innate immune response. RIP2 is a downstream kinase activated by both NOD1 and NOD2. There is scarcity of information regarding the relevance of NOD2 in periodontitis, a chronic inflammatory condition characterized by inflammatory bone resorption. We used NOD2-KO and RIP2-KO mice in a model of microbial-induced periodontitis. Heat-killed Aggregatibacter actinomycetemcomitans was injected in the gingival tissues three times/wk for 4 wk. Bone resorption was assessed by μCT analysis; osteoclasts were identified by immunohistochemical staining for TRAP and inflammation was assessed using a severity score system in H/E-stained sections. In vitro studies using primary macrophages assessed the response macrophages using qPCR-based array and multi-ligand ELISA. Bone resorption and osteoclastogenesis were significantly reduced in NOD2-KO mice. Severity of inflammation was not affected. qPCR-focused arrays and multi-ligand ELISA showed that expression of pro-inflammatory mediators was reduced in NOD2- and RIP2-deficient cells. RANKL-induced osteoclastogenesis was impaired in NOD2- and RIP2-deficient macrophages. We conclude that NOD2 is important for osteoclast differentiation and inflammatory bone resorption in vivo and also for the macrophage response to Gram-negative bacteria.

[1]  J. Raes,et al.  Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity. , 2013, Cell host & microbe.

[2]  A. Gustafsson,et al.  Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  P. Ward,et al.  Fingerprinting of the TLR4-induced acute inflammatory response. , 2012, Experimental and molecular pathology.

[4]  Derek W. Abbott,et al.  Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease. , 2012, Biochimica et biophysica acta.

[5]  D. Philpott,et al.  Nod-like receptors in the control of intestinal inflammation. , 2012, Current opinion in immunology.

[6]  J. Ting,et al.  ASC-dependent RIP2 Kinase Regulates Reduced PGE2 Production in Chronic Periodontitis , 2012, Journal of dental research.

[7]  D. Graves,et al.  Diabetes aggravates periodontitis by limiting repair through enhanced inflammation , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  岸本 隆明 Peptidoglycan and lipopolysaccharide synergistically enhance bone resorption and osteoclastogenesis , 2012 .

[9]  R. Schwarzenbacher,et al.  Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation , 2012, Innate immunity.

[10]  D. Philpott,et al.  Examining host-microbial interactions through the lens of NOD: From plants to mammals. , 2012, Seminars in immunology.

[11]  P. Cresswell,et al.  TLR and Nucleotide-Binding Oligomerization Domain-like Receptor Signals Differentially Regulate Exogenous Antigen Presentation , 2012, The Journal of Immunology.

[12]  K. Riesbeck,et al.  Effects of NOD‐like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll‐like receptors , 2011, Journal of leukocyte biology.

[13]  P. Sansonetti,et al.  NLR functions beyond pathogen recognition , 2011, Nature Immunology.

[14]  D. Zamboni,et al.  A Method for Generation of Bone Marrow-Derived Macrophages from Cryopreserved Mouse Bone Marrow Cells , 2010, PloS one.

[15]  C. Streutker,et al.  Nod1 and Nod2 Regulation of Inflammation in the Salmonella Colitis Model , 2010, Infection and Immunity.

[16]  J. Chou,et al.  NOD2-associated diseases: Bridging innate immunity and autoinflammation. , 2010, Clinical immunology.

[17]  N. Silverman,et al.  NOD1 and NOD2 Mediate Sensing of Periodontal Pathogens , 2010, Journal of dental research.

[18]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[19]  K. Chung,et al.  Differential regulation of CCL-11/eotaxin-1 and CXCL-8/IL-8 by Gram-positive and Gram-negative bacteria in human airway smooth muscle cells , 2008, Respiratory research.

[20]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[21]  D. Graves,et al.  Diabetes Enhances Periodontal Bone Loss through Enhanced Resorption and Diminished Bone Formation , 2006, Journal of dental research.

[22]  Setsuya Aiba,et al.  Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells , 2005, Infection and Immunity.

[23]  S. Akira,et al.  Muramyl Dipeptide Enhances Osteoclast Formation Induced by Lipopolysaccharide, IL-1α, and TNF-α through Nucleotide-Binding Oligomerization Domain 2-Mediated Signaling in Osteoblasts1 , 2005, The Journal of Immunology.

[24]  M. Uguccioni,et al.  CCL22‐induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first β‐strand of chemokine , 2005, European journal of immunology.

[25]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[26]  S. Akira,et al.  Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. , 2005, Journal of immunology.

[27]  C. Janeway,et al.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.

[28]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.